A Japan-based biopharmaceutical company focused on developing and commercializing prescription medicines, particularly in oncology and immunology. The firm operates as a key member of the Roche Group, collaborating closely with the Swiss drugmaker on research, development, and global commercializati...
4 members of Congress have disclosed 14 trades in Chugai Pharmaceutical Co., Ltd. (CHGCY), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-04-09 | Josh Gottheimer | sell | $1K – $15K |
| 2024-06-21 | Josh Gottheimer | sell | $1K – $15K |
| 2024-04-04 | Josh Gottheimer | sell | $1K – $15K |
| 2023-08-18 | Josh Gottheimer | buy | $1K – $15K |
| 2023-07-10 | Daniel Goldman | sell | $1K – $15K |
| 2023-03-31 | Daniel Goldman | sell | $15K – $50K |
| 2023-02-27 | Daniel Goldman | buy | $1K – $15K |
| 2021-02-17 | Peter Meijer | sell | $15K – $50K |
| 2020-04-14 | Greg Gianforte | sell | $50K – $100K |
| 2020-04-13 | Josh Gottheimer | sell | $1K – $15K |
| 2020-01-13 | Greg Gianforte | buy | $15K – $50K |
| 2019-03-01 | Greg Gianforte | buy | $100K – $250K |
| 2019-02-20 | Josh Gottheimer | buy | $1K – $15K |
| 2019-02-19 | Josh Gottheimer | buy | $1K – $15K |